Lauren Flaxenburg
About Lauren Flaxenburg
Lauren Flaxenburg is a Quality Control Analyst at Suvoda, where she has worked since 2021. She holds a Bachelor of Science in Animal Sciences from the University of Rhode Island and has previous experience in food service and analytical chemistry.
Work at Suvoda
Lauren Flaxenburg has been employed at Suvoda as a Quality Control Analyst since 2021. In this role, she contributes to the company's focus on clinical trial technology, specifically for complex therapeutic areas such as oncology, CNS, and rare diseases. Her work supports clinical trial professionals by ensuring the quality and reliability of software solutions provided on a single platform. Suvoda has a global presence, with offices located in the United States, Spain, Romania, and Japan.
Education and Expertise
Lauren Flaxenburg studied at the University of Rhode Island, where she earned a Bachelor of Science in Animal Sciences from 2015 to 2020. Prior to her university education, she attended Twin Valley High School from 2011 to 2015. This educational background has provided her with a solid foundation in scientific principles, which she applies in her current role in quality control.
Previous Work Experience
Before joining Suvoda, Lauren Flaxenburg worked at Catalent Pharma Solutions as an Analytical Chemist from 2019 to 2021. Her experience also includes serving as a Food Server at Nonno Alby’s Brick Oven Pizza from 2016 to 2020 and at Petrangeli’s from 2013 to 2015. Additionally, she briefly worked as a Veterinary Assistant at Country Companion Animal Hospital in 2016. This diverse work history has equipped her with a range of skills applicable to her current position.
Professional Contributions
In her role as a Quality Control Analyst at Suvoda, Lauren Flaxenburg is part of a team that supports clinical trial professionals with advanced software solutions. Her contributions help ensure that the technology used in clinical trials meets high standards of quality and reliability, which is essential for the success of trials in complex therapeutic areas.